Biosensors International has announced the results of the BIO-RISE CHINA study
November 6th 2021. In a Late Breaking Clinical Trials session at TCT, Biosensors has announced the results of the BIO-RISE CHINA study, a Randomized Trial of a Biolimus-Coated Balloon Versus Plain Balloon Angioplasty in Patients with Small Vessel Coronary Artery Disease
MORGES, Switzerland,